Rocket Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rocket Pharmaceuticals, Inc. Common Stock (RCKT) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.5%, relative volume 2.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
11 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RCKT is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $10M notional. Top 3 carry $26M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $10M |
| XBIState Street SPDR S&P Biotech ETF | 0.13% | $9M |
| IWMiShares Russell 2000 ETF | 0.01% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $416K |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $416K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RCKT Jan avg: -2.13% median: -2.50% win: 25% σ: 10.54% n: 4 2022-04-12 → 2026-05-29 | RCKT Feb avg: 5.58% median: -4.81% win: 50% σ: 26.40% n: 4 2022-04-12 → 2026-05-29 | RCKT Mar avg: -19.21% median: -19.68% win: 0% σ: 11.34% n: 4 2022-04-12 → 2026-05-29 | RCKT Apr avg: -5.81% median: -2.79% win: 40% σ: 16.61% n: 5 2022-04-12 → 2026-05-29 | RCKT May avg: -9.55% median: -0.93% win: 40% σ: 34.29% n: 5 2022-04-12 → 2026-05-29 | RCKT Jun avg: 2.41% median: -0.70% win: 50% σ: 9.47% n: 4 2022-04-12 → 2026-05-29 (current) | RCKT Jul avg: 8.28% median: 8.89% win: 75% σ: 14.05% n: 4 2022-04-12 → 2026-05-29 | RCKT Aug avg: -5.40% median: -3.51% win: 50% σ: 14.67% n: 4 2022-04-12 → 2026-05-29 | RCKT Sep avg: 7.97% median: 1.48% win: 50% σ: 15.49% n: 4 2022-04-12 → 2026-05-29 | RCKT Oct avg: 2.76% median: 2.90% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-05-29 | RCKT Nov avg: 1.80% median: -4.05% win: 50% σ: 19.09% n: 4 2022-04-12 → 2026-05-29 | RCKT Dec avg: 5.53% median: 3.14% win: 75% σ: 17.01% n: 4 2022-04-12 → 2026-05-29 |